Spanish vaccine against HIV showing 90 percent success

 

Spanish vaccine against the HIV virus is showing 90% success. The CSIC, Superior Centre for Scientific Investigation, has today Wednesday presented the first results of tests on humans and they show promising results against the virus. The CSIC has developed and patented the vaccine which has managed to trigger an immune response against the virus in 90% of the people who have been given it. The research also shows that the effects remain for at least a year in 85% of cases. Researcher at the National Biotechnology Centre, Mariano Esteban, who took part in the research at both the Clinic Hospital in Barcelona and the Gregorio Marañón Hospital in Madrid, noted that there were no serious side effects to the vaccine, which goes under the name ‘MVA-B’. The doctor responsible for the investigating team in Barcelona, Felipe García, has said that the results should be taken with caution, because the phase one tests have been carried out on only 30 volunteers. There is more on this story in the medical journals, 'Vaccine' and 'Journal of Virology'